Join
Live feed
·
PRReleasevia Quantisnow
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies

ByQuantisnow·Wall Street's wire, on your screen.
XTLB· XTL Biopharmaceuticals Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XTLB (XTL Biopharmaceuticals Ltd.) and more on Quantisnow.